Disease · MONDO_0005689
Comparisons in its trials41
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
1 to 20 of 41
Download this page as JSON| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| Gabapentin 1200mg/Day vs Placebo: serious adverse events | 0 of 150 | 1 of 150 | 300 | NCT00974376 | Trial comparisons |
| N-acetylcysteine vs Placebo: deaths from any cause | 0 of 98 | 0 of 94 | 192 | NCT03055377 | Trial comparisons |
| N-acetylcysteine vs Placebo: serious adverse events | 0 of 98 | 0 of 94 | 192 | NCT03055377 | Trial comparisons |
| Varenicline vs Placebo: deaths from any cause | 0 of 90 | 0 of 84 | 174 | NCT03980561 | Trial comparisons |
| Varenicline vs Placebo: serious adverse events | 1 of 90 | 0 of 84 | 174 | NCT03980561 | Trial comparisons |
| Quetiapine vs Placebo: deaths from any cause | 0 of 66 | 0 of 64 | 130 | NCT01697709 | Trial comparisons |
| Quetiapine vs Placebo: serious adverse events | 0 of 66 | 0 of 64 | 130 | NCT01697709 | Trial comparisons |
| Lofexidine and Dronabinol vs Placebo: 21 Days of Consecutive Abstinence as Measured by the Time-line Followback. | 17 of 61 | 18 of 61 | 122 | NCT01020019 | Trial comparisons |
| Lofexidine and Dronabinol vs Placebo: serious adverse events | 1 of 61 | 1 of 61 | 122 | NCT01020019 | Trial comparisons |
| N-Acetylcysteine vs Placebo: deaths from any cause | 0 of 58 | 0 of 58 | 116 | NCT01005810 | Trial comparisons |
| N-Acetylcysteine vs Placebo: serious adverse events | 0 of 58 | 0 of 58 | 116 | NCT01005810 | Trial comparisons |
| Vilazodone vs Placebo: serious adverse events | 0 of 41 | 0 of 35 | 76 | NCT01574183 | Trial comparisons |
| Fluoxetine vs Placebo: serious adverse events | 0 of 34 | 0 of 36 | 70 | NCT00149643 | Trial comparisons |
| Aprepitant: 125mg/Day vs Matched Placebo: serious adverse events | 0 of 32 | 0 of 38 | 70 | NCT01611948 | Trial comparisons |
| PF-04457845 (4mg by Mouth Daily for 4 Weeks) vs Placebo (Sugar Pill, by Mouth Daily for 4 Weeks): deaths from any cause | 0 of 46 | 0 of 24 | 70 | NCT01618656 | Trial comparisons |
| PF-04457845 (4mg by Mouth Daily for 4 Weeks) vs Placebo (Sugar Pill, by Mouth Daily for 4 Weeks): serious adverse events | 0 of 46 | 0 of 24 | 70 | NCT01618656 | Trial comparisons |
| Clonazepam vs Placebo: deaths from any cause | 0 of 34 | 0 of 34 | 68 | NCT02913924 | Trial comparisons |
| Clonazepam vs Placebo: serious adverse events | 1 of 34 | 1 of 34 | 68 | NCT02913924 | Trial comparisons |
| Non-Randomized Participants vs Placebo/Dronabinol: deaths from any cause | 0 of 37 | 0 of 24 | 61 | NCT00480441 | Trial comparisons |
| Non-Randomized Participants vs Placebo/Dronabinol: serious adverse events | 0 of 37 | 0 of 24 | 61 | NCT00480441 | Trial comparisons |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0005689/comparisons